Expert in Cardiogenetics & Precision Medicine

Advancing personalized care and innovative research for patients with inherited heart diseases.

Clinical Excellence

Managed over 5,000 patient cases in the fields of cardiogenetics and oncogenetics

Affiliated Institutions and Collaborations

Assistance Publique - Hôpitaux de Paris Sapienza Università di Roma Université Paris Cité Università degli Studi di Perugia Harvard Medical School Qatar University
Male cardiologist with stethoscope in professional setting

Advancing Precision Medicine

Through cutting-edge research and personalized patient care, we're transforming the future of inherited cardiac disorder treatment and genetic counseling.

About Dr. Mohamed El Hachmi

Dr. Mohamed El Hachmi is a Cardiogeneticist specializing in Precision Medicine, with dual PhDs from Sapienza University of Rome and Paris Cité University. His research focuses on rare inherited heart diseases, with particular expertise in Hypertrophic Cardiomyopathy (HCM), Vascular Ehlers-Danlos Syndrome (vEDS), and Cardiac Amyloidosis (ATTR).

Dual PhD

Sapienza University of Rome & Paris Cité University

Executive Board Member

European Board of Medical Genetics (EBMG)

Former Cardiogeneticist

Hôpital Européen Georges Pompidou, Paris

Full Biography

Research Focus Areas

Hypertrophic Cardiomyopathy (HCM)

HCM

Leading the GEREMY Registry for genetic profiling and precision treatment eligibility in HCM patients. Developing risk stratification models based on genetic variants.

For Patients

HCM causes the heart muscle to thicken, making it harder to pump blood. We're studying genetic factors to improve treatment options and predict who may develop symptoms.

Inherited Dilated Cardiomyopathies and Neuromuscular Disorders: Genetics, Risk Stratification, and Clinical Management

DCM

Comprehensive research on genetic and phenotypic determinants of disease progression in dilated cardiomyopathy, with specialized focus on laminopathies and neuromuscular cardiomyopathies.

For Patients

We study inherited forms of dilated cardiomyopathy to identify high-risk patients early and develop personalized treatment strategies to prevent complications.

Arrhythmogenic Cardiomyopathy (ACM)

ACM

Expert diagnosis, risk stratification and management of this complex disease using multidisciplinary approach integrating clinical assessment, advanced imaging and cardiovascular genetics.

For Patients

ACM is a rare inherited heart condition that can cause dangerous heart rhythms. We work to identify patients at risk and provide personalized care to prevent sudden cardiac events.

Polygenic Risk Scores (PRS) in Cardiovascular Disease

PRS

Expert Lead: Dr. El Hachmi – Genetic Counselling & PRS Specialist. Recognized expertise in integrating PRS into personalized cardiovascular prevention, focusing on atrial fibrillation, coronary artery disease, and hypercholesterolemia.

For Patients

If you have a family history of cardiovascular disease or have received an early diagnosis, PRS testing may help you understand your genetic risk profile and support more personalized treatment decisions.

Latest News

Stay updated with our latest research publications and clinical developments

Advanced genetic research laboratory with DNA analysis and molecular diagnostics
New

Featured Publication

Read our chapter in Encyclopedia of the Neurological Sciences

Explore our comprehensive chapter on cardiac involvement with or without myopathy in the prestigious Encyclopedia of the Neurological Sciences, Third Edition. This authoritative reference covers major advances in neurobiology and clinical neurosciences.

Encyclopedia of the Neurological Sciences, 3rd Edition • 2025
Read Full Chapter

Recent Updates

New Research Collaboration Announced

Dr. El Hachmi joins international consortium for cardiogenetics research

January 2025

GEREMY Registry Milestone

French HCM registry reaches 1,500 enrolled patients

December 2024

ARCADE Trial Results

Breakthrough findings in vEDS treatment published

November 2024

Stay Connected

Follow our research updates and clinical developments

View All Publications

Latest Publications

2025

Irbesartan and celiprolol combination therapy for vascular Ehlers-Danlos syndrome

Circulation

Read more →
2024

French Hypertrophic Cardiomyopathy Genetic Registry: 5-year outcomes and risk stratification

International Journal of Cardiology

Read more →
2024

Genetic Testing Score for Arrhythmogenic Left Ventricular Cardiomyopathy

Circulation: Genomic and Precision Medicine

Read more →

Seeking Collaborative Research Opportunities

Dr. El Hachmi is actively looking for research partners in multicenter studies, cohort data sharing, and genetic screening programs for inherited cardiac disorders.